Francescantonio Cammarota
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells.
Journal: Cephalalgia : an international journal of headache
Published: December 04, 2025
Real world effectiveness of anti-CGRP monoclonal antibodies over three consecutive one-year treatment cycles: An intention-to-treat analysis.
Journal: Cephalalgia : an international journal of headache
Published: August 07, 2025
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial.
Journal: Cephalalgia : an international journal of headache
Published: May 19, 2025
Clinical and instrumental gait phenotyping in people with GLUT-1 deficiency syndrome.
Journal: Gait & posture
Published: January 28, 2025
Split syndrome with acute-onset hemichorea and contralateral progressive parkinsonism: a case report.
Journal: Acta neurologica Belgica
Published: November 27, 2024
High-frequency episodic migraine: Time for its recognition as a migraine subtype?
Journal: Cephalalgia : an international journal of headache
Published: October 22, 2024
Correction: Expression of miR‑155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile.
Journal: The journal of headache and pain
Published: October 15, 2024
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression.
Journal: Sensors (Basel, Switzerland)
Published: August 09, 2024
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile.
Journal: The journal of headache and pain
Published: April 29, 2024
The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study.
Journal: The journal of headache and pain
Published: December 29, 2023
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial.
Journal: The journal of headache and pain
Published: July 05, 2022
Last Updated: 09/26/2026